The Psychonauts’ World of Cognitive Enhancers
Abstract Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in…
Novel psychoactive substances
Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
Abstract Parkinson’s Disease (PD) is currently the most rapid growing neurodegenerative disease and over the past generation, its global burden…
Novel Psychoactive Substances in Custodial Settings: A Mixed Method Investigation on the Experiences of People in Prison and Professionals Working With Them
Abstract Introduction: Novel Psychoactive Substances (NPS), especially Synthetic Cannabinoid Receptor Agonists (SCRAs), pose a substantial challenge to health and the…
Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
Abstract Background: Synthetic cannabinoid receptor agonists (SCRAs) have become the largest group of new psychoactive substances monitored by the European…
Abuse of Licit and Illicit Psychoactive Substances in the Workplace: Medical, Toxicological, and Forensic Aspects
Abstract About one-third of adult life is spent in the workplace. The use of psychoactive substances is a major preventable…
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
Abstract Synthetic cannabinoid receptor agonists (SCRAs) are the largest class of new psychoactive substances (NPS). New examples are detected constantly,…
New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites
Abstract Synthetic cannabinoids (SCs) were initially developed as pharmacological tools to probe the endocannabinoid system and as novel pharmacotherapies, but…
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues
Abstract Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis…
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants
Abstract New psychoactive substances (NPS) are a heterogeneous and rapidly evolving class of molecules available on the global illicit drug…